Home › Post-COVID Conditions (Long COVID) › NCT05796505

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All incarcerated people in the Pennsylvania DOC are included in the study population for these low risk interventions. In this each individual intervention, inclusion criteria will be based on where incarcerated people are housed and therefore what intervention they will be exposed to.

Exclusion Criteria:

* Exclusion criteria will likely include severe physical or mental illness as these individuals are often incarcerated in special units which will not be included in the study (i.e. medical units).

About the study

The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison system.

What is being tested

• ADVANCE Steering Committee interventions (behavioral)

Sponsor: Yale University · Participants: 37,122 · Started: Jul 23, 2024

Contact the study team

• Lisa B Puglisi, MD · Phone: 475-306-1023

Official record on ClinicalTrials.gov — NCT05796505

Locations in the U.S.

Conditions

• Post-COVID Conditions (Long COVID)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.